Most Recent
Global law firm Jones Day has recruited two corporate partners from rival Hogan Lovells to join its transactions team in Sydney.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
The co-owners of Pacific Werribee shopping centre in Victoria have won their bid for a preliminary trial in a suit against Probuild Constructions and several engineering companies over $200 million in alleged structural defects.
Longtime tax partner at Baker McKenzie has made the jump to Jones Day, joining the firm's Sydney office.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Gaming giant Aristocrat has defeated a challenge by Light & Wonder to discovery orders it won for a possible lawsuit alleging two former employees who jumped ship to its rival misused confidential information about its popular Lightning Link and Dragon Link games.
Jones Day has bolstered its financial markets practice with the addition of a former Baker McKenzie special counsel.
A judge has rejected Aristocrat’s bid for orders requiring competitor Light & Wonder to hand over documents to be placed “in an envelope” for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.